Literature DB >> 10069511

Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects.

G Wallukat1, H M Fu, S Matsui, A Hjalmarson, M L Fu.   

Abstract

Circulating autoantibodies against the human M2 muscarinic receptors have been previously shown in 38% of patients with idiopathic dilated cardiomyopathy. The functional properties of these autoantibodies are reported herein. They were able to decrease the cell beating frequency of myocytes in cultured neonatal rat heart cells in a dose-dependent manner without desensitization over a period of more than 5 hours whereas the non-specific muscarinic receptor agonist carbachol also inhibited the heart cell beating frequency but was desensitized within 1 hour. In the same cell culture, anti-M2 muscarinic receptor autoantibodies were not able to induce internalization of muscarinic receptor whereas carbachol did. These results demonstrate for the first time that anti-M2 muscarinic receptor autoantibodies from patients with idiopathic dilated cardiomyopathy have stimulatory muscarinic activity in vitro, which differ from normal muscarinic agonists by non-desensitization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069511     DOI: 10.1016/s0024-3205(98)00589-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

Review 1.  Autoantibodies as Endogenous Modulators of GPCR Signaling.

Authors:  Meredith A Skiba; Andrew C Kruse
Journal:  Trends Pharmacol Sci       Date:  2020-12-24       Impact factor: 14.819

Review 2.  Autoantibodies and cardiovascular dysfunction: cause or consequence?

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 3.  The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 4.  Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.

Authors:  Gerd Wallukat; Ingolf Schimke
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

5.  Implications of a vasodilatory human monoclonal autoantibody in postural hypotension.

Authors:  Hongliang Li; Jonathan Zuccolo; David C Kem; Caitlin Zillner; Jiyeon Lee; Kenneth Smith; Judith A James; Madeleine W Cunningham; Xichun Yu
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

6.  Experimental study on AT1-receptor-peptide-induced myocardial immune damage in rat.

Authors:  Y Luo; Y Liao; M Wang; Y Wei; J Dong; I Wang; Y Lu
Journal:  J Tongji Med Univ       Date:  2001

Review 7.  Angiotensin receptors, autoimmunity, and preeclampsia.

Authors:  Yang Xia; Cissy Chenyi Zhou; Susan M Ramin; Rodney E Kellems
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

8.  Antibodies to cardiac receptors.

Authors:  V Boivin-Jahns; A Schlipp; S Hartmann; P Panjwani; K Klingel; M J Lohse; G Ertl; R Jahns
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

Review 9.  Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.

Authors:  Yang Xia; Rodney E Kellems
Journal:  Circ Res       Date:  2013-06-21       Impact factor: 17.367

10.  Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies.

Authors:  Wai Hong Wilson Tang; Sathyamangla V Naga Prasad
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.